Center for Substance Abuse Prevention; Notice of Cancellation of Meeting, 11185-11186 [2010-5076]
Download as PDF
<![CDATA[
11185
Federal Register / Vol. 75, No. 46 / Wednesday, March 10, 2010 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Demonstrators .............................................................................................................................
Demonstrators .............................................................................................................................
Demonstrators .............................................................................................................................
Demonstrators .............................................................................................................................
Observers ....................................................................................................................................
Observers ....................................................................................................................................
Observers ....................................................................................................................................
Observers ....................................................................................................................................
Dated: March 4, 2010.
Maryam Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–5156 Filed 3–9–10; 8:45 am]
Centers for Medicare & Medicaid
Services; Delegation of Authority
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review;
Comment Request; Reinstatement of
OMB No. 0925–0601/exp. 02/28/2010,
Request for Human Embryonic Stem
Cell Line To Be Approved for Use in
NIH Funded Research
ACTION:
Correction notice.
erowe on DSK5CLS3C1PROD with NOTICES
On March 2, 2010 the National
Institutes of Health published a notice
in the Federal Register (75 FR 9418)
with a 30-day comment period seeking
public comment for an information
collection entitled ‘‘Request for Human
Embryonic Stem Cell Line to be
Approved for Use in NIH Funded
Research’’.
In the second paragraph of the notice
entitled, ‘‘Proposed Collection,’’ the
annual reporting burden reflected in the
notice is corrected to read: ‘‘Estimated
Number of Respondents: 100; Estimated
Number of Responses per Respondent:
1; Average Burden Hours Per Response:
3; and Estimated Total Annual Burden
Hours Requested: 300. The estimated
annualized cost to respondents is
$10,500.’’
All other information in the notice is
correct and remains unchanged.
Dated: March 2, 2010.
Mikia Currie,
Office of Policy for Extramural Research
Administration, OD, National Institutes of
Health.
[FR Doc. 2010–5020 Filed 3–9–10; 8:45 am]
BILLING CODE 4140–01–P
VerDate Nov<24>2008
15:07 Mar 09, 2010
Jkt 220001
Office of the Secretary
Notice is hereby given that I have
delegated to the Administrator, Centers
for Medicare & Medicaid Services
(CMS), or his or her successor, the
authorities currently vested in the
Secretary under section 1135 [42 U.S.C.
1320b–5] of Title XI of the Social
Security Act, and as may hereafter be
amended, to temporarily waive or
modify requirements during certain
emergencies or disasters that are related
to Medicare, Medicaid, and the
Children’s Health Insurance Programs as
they pertain to the mission of CMS.
The authorities under section 1135
[42 U.S.C. 1320b–5] of the Social
Security Act, and as may hereafter be
amended, may be re-delegated.
Limitations
1. The authority to make the initial
decision to invoke the waiver
authorities under section 1135 [42
U.S.C. 1320b–5] upon the occurrence of
the two conditions precedent specified
in section 1135(g) [42 U.S.C. 1320b–
5(g)] is excluded from this delegation
and is reserved by me.
2. The following authorities under
section 1135 [42 U.S.C. 1320b–5] of the
Social Security Act, and as may
hereafter be amended, are excluded
from this delegation of authority:
—Section 1135(b)(7) pertaining to
sanctions and penalties that arise from
noncompliance with certain
requirements of regulations
promulgated under section 264(c) of the
Health Insurance Portability and
Accountability Act of 1996 (HIPAA) [42
U.S.C. 1320d–2 note]. The authority to
waive the HIPAA regulations at 45 of
the Code of Federal Regulations, Part
164 will continue to be held by me.
—Section 1135(d) to provide a
certification and advance written notice
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
30
30
30
30
170
170
170
170
Average
burden per
response
(in hours)
1
1
1
1
1
1
1
1
15/60
15/60
15/60
3
15/60
15/60
15/60
3
to Congress at least two days before
exercising the authority with respect to
an emergency area is reserved by me.
—Section 1135(f) to report to Congress
regarding the approaches used to
accomplish the purposes described in
section 1135(a) [42 U.S.C. 1320b–5] of
the Social Security Act, including an
evaluation of such approaches and
recommendations for improved
approaches should the need for such
emergency authority arise in the future
is reserved by me.
3. The authorities under section 1135
[42 U.S.C. 1320b–5] shall be exercised
under the Department’s policy on
regulations and the existing delegation
of authority to approve and issue
regulations.
I hereby affirm and ratify any actions
taken by the Administrator, CMS, or his
or her subordinates, which involved the
exercise of the authorities under section
1135 [42 U.S.C. 1320b–5] delegated
herein prior to the effective date of this
delegation of authority.
This delegation of authority is
effective immediately.
Authority: 44 U.S.C. 3101.
Kathleen Sebelius,
Secretary.
[FR Doc. 2010–4992 Filed 3–9–10; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Prevention; Notice of Cancellation of
Meeting
Pursuant to Public Law 92–462,
notice is hereby given of a cancellation
of the March 8, 2010 meeting of the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
Drug Testing Advisory Board (DTAB).
Public notice was given in the Federal
Register on February 19, 2010 (Volume
E:\FR\FM\10MRN1.SGM
10MRN1
11186
Federal Register / Vol. 75, No. 46 / Wednesday, March 10, 2010 / Notices
75, Number 33, and Page 7483) that the
DTAB would be meeting on March 8,
2010, in the Sugarloaf and Seneca
Conference Rooms, 1 Choke Cherry
Road, Rockville, Maryland. The meeting
was canceled due to unforeseen
circumstances. An alternate date, time
and location for the meeting will be
announced in the Federal Register
when arrangements have been made.
Members of the public wishing
further information concerning this
cancellation notice or any future
meetings of the DTAB should contact
the Designated Federal Official, Donna
M. Bush, PhD, 1 Choke Cherry Road,
Room 2–1033, Rockville, MD 20857,
Telephone: 240–276–2600, FAX: 240–
276–2610.
Toian Vaughn,
Committee Management Officer, Substance
Abuse and Mental Health Services
Administration.
[FR Doc. 2010–5076 Filed 3–9–10; 8:45 am]
National Institutes of Health
National Center for Complementary
and Alternative Medicine
Announcement of Workshop on
Natural Products
erowe on DSK5CLS3C1PROD with NOTICES
SUMMARY: As part of its strategic
planning process, the National Center
for Complementary and Alternative
Medicine (NCCAM) invites the public to
attend and observe at a Workshop on
Natural Products. The purpose of this
workshop is to inform the NCCAM’s
third strategic plan by identifying
particularly promising areas with the
potential to yield new information about
CAM natural product treatments.
The Workshop will take place on
March 26, 2010 in Bethesda, Maryland.
Those interested in CAM research are
particularly encouraged to attend.
Seating is limited.
Background: The National Center for
Complementary and Alternative
Medicine (NCCAM) was established in
1998 with the mission of exploring
complementary and alternative healing
practices in the context of rigorous
science, training CAM researchers, and
disseminating authoritative information
to the public and professionals.
To date, NCCAM’s efforts to
rigorously study CAM, to train CAM
researchers, and to communicate with
the public and professionals, have been
guided by NCCAM’s previous strategic
Jkt 220001
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Notice.
15:07 Mar 09, 2010
[FR Doc. 2010–5164 Filed 3–9–10; 8:45 am]
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Nov<24>2008
Dated: March 3, 2010.
Jack Killen,
Deputy Director, National Center for
Complementary and Alternative Medicine,
National Institutes of Health.
Centers for Disease Control and
Prevention
BILLING CODE 4162–20–P
ACTION:
plans, located on the NCCAM Web site
at https://nccam.nih.gov/about/plans.
Participating: The Workshop will take
place on March 26, 2010 from 8:15 a.m.
to 4:30 p.m. on the NIH campus in
Bethesda, Maryland.
FOR FURTHER INFORMATION CONTACT: To
request more information, visit the
NCCAM Web site at https://
nccam.nih.gov, call Carina May at
301–915–9763, or e-mail
CMay@Thehillgroup.com.
Time and Date: 11 a.m.–3 p.m., March 31,
2010.
Place: Audio Conference Call via FTS
Conferencing. The USA toll free dial in
number is 1(866)659–0537 with a pass code
of 9933701.
Status: Open to the public, but without a
public comment period.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
PO 00000
Frm 00083
Fmt 4703
Sfmt 9990
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
3, 2001, renewed at appropriate intervals,
most recently, August 3, 2009, and will
expire on August 3, 2011.
Purpose: This Advisory Board is charged
with (a) Providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters to be Discussed: The agenda for the
conference call includes: SEC Petitions for:
Canoga Avenue Facility (Los Angeles County,
CA), University of Rochester Atomic Energy
Project, Blockson Chemical, and Chapman
Valve; NIOSH 10–Year Review of OCAS
Program; OCAS Facility Records Search
Methods; NIOSH Office of Compensation
Analysis and Support Analysis of SEC Class
Definitions; Board Subcommittee and Work
Group Updates; and, OCAS SEC Petition
Evaluations Update for May 2010 Board
Meeting.
The agenda is subject to change as
priorities dictate.
Because there is not a public comment
period, written comments may be submitted.
Any written comments received will be
included in the official record of the meeting
and should be submitted to the contact
person below in advance of the meeting.
Contact Person for More Information:
Theodore M. Katz, M.P.A., Executive
Secretary, NIOSH, CDC, 1600 Clifton Road,
NE., Mailstop E–20, Atlanta, GA 30333,
Telephone: (513)533–6800, Toll Free:
1(800)CDC–INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 3, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–5159 Filed 3–9–10; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\10MRN1.SGM
10MRN1
]]>Agencies
[Federal Register Volume 75, Number 46 (Wednesday, March 10, 2010)]
[Notices]
[Pages 11185-11186]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-5076]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Prevention; Notice of Cancellation of
Meeting
Pursuant to Public Law 92-462, notice is hereby given of a
cancellation of the March 8, 2010 meeting of the Substance Abuse and
Mental Health Services Administration (SAMHSA) Drug Testing Advisory
Board (DTAB).
Public notice was given in the Federal Register on February 19,
2010 (Volume
[[Page 11186]]
75, Number 33, and Page 7483) that the DTAB would be meeting on March
8, 2010, in the Sugarloaf and Seneca Conference Rooms, 1 Choke Cherry
Road, Rockville, Maryland. The meeting was canceled due to unforeseen
circumstances. An alternate date, time and location for the meeting
will be announced in the Federal Register when arrangements have been
made.
Members of the public wishing further information concerning this
cancellation notice or any future meetings of the DTAB should contact
the Designated Federal Official, Donna M. Bush, PhD, 1 Choke Cherry
Road, Room 2-1033, Rockville, MD 20857, Telephone: 240-276-2600, FAX:
240-276-2610.
Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health
Services Administration.
[FR Doc. 2010-5076 Filed 3-9-10; 8:45 am]
BILLING CODE 4162-20-P
